{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:11:20Z","timestamp":1793362280543,"version":"4.5.0"},"reference-count":85,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.1080\/14656566.2026.2654682","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:12:02Z","timestamp":1775553122000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations"],"prefix":"10.1080","volume":"27","author":[{"given":"Donatella","family":"Marazziti","sequence":"first","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gambini","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Gurrieri","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]},{"name":"School of Advanced Studies","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Russomanno","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sit\u00e0","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pescini","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Rita","family":"Digiuseppe","sequence":"additional","affiliation":[{"name":"University of Pisa","place":["Pisa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mucci","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Lucca Zone","place":["Lucca, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104938"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2023.11.003"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2445016"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.141124"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253231198466"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1037\/sah0000546"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104242"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.887255"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109257"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119220"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.06.053"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117049"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2023.120097"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009019"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01316-5"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106132"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15020117"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1121-22.2022"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114568039"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063972"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.2546"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15010253"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyae057"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2025.152619"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2025.09.011"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.31486\/toj.23.0076"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115886"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61020278"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16762"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0364-7722(79)90064-X"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.25com16003"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.1189"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050702"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2024.0026"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109232"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1017\/jme.2025.10183"},{"key":"e_1_3_5_42_1","unstructured":"Orhurhu VJ Roberts JS Ly NK et al. Ketamine in acute and chronic pain management. StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Feb 7]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539824\/"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3478"},{"key":"e_1_3_5_44_1","unstructured":"FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs | FDA [Internet]. [cited 2026 Feb 7]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs"},{"key":"e_1_3_5_45_1","unstructured":"EMA multi-stakeholder workshop on psychedelics \u2013 towards an EU regulatory framework | European medicines agency (EMA) [Internet]. 2023 [cited 2026 Feb 7]. Available from: https:\/\/www.ema.europa.eu\/en\/events\/ema-multi-stakeholder-workshop-psychedelics-towards-eu-regulatory-framework"},{"key":"e_1_3_5_46_1","unstructured":"Oregon health authority: Oregon psilocybin services: prevention and wellness: state of oregon [Internet]. [cited 2026 Feb 7]. Available from: https:\/\/www.oregon.gov\/oha\/ph\/preventionwellness\/pages\/oregon-psilocybin-services.aspx?utm_source=chatgpt.com"},{"key":"e_1_3_5_47_1","unstructured":"Administration (TGA) TG. Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists | therapeutic Goods administration (TGA) [Internet]. Therapeutic Goods Administration (TGA); 2023 [cited 2026 Feb 7]. Available from: https:\/\/www.tga.gov.au\/news\/media-releases\/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists"},{"key":"#cr-split#-e_1_3_5_48_1.1","unstructured":"Administration (TGA) TG. Notice of final decision to amend (or not amend) the current poisons standard - June 2022 ACMS #38 - psilocybine and MDMA | therapeutic Goods administration (TGA) [Internet]. Therapeutic Goods Administration (TGA)"},{"key":"#cr-split#-e_1_3_5_48_1.2","unstructured":"2023 [cited 2026 Feb 7]. Available from: https:\/\/www.tga.gov.au\/resources\/publication\/scheduling-decisions-final\/notice-final-decision-amend-or-not-amend-current-poisons-standard-june-2022-acms-38-psilocybine-and-mdma"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2025.105525"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101537"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1310218"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674241289024"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-10024-8"},{"key":"e_1_3_5_54_1","unstructured":"Janssen Announces U.S. FDA approval of SPRAVATOTM (esketamine) CIII nasal spray for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief [Internet]. JNJ.com. 2019 [cited 2026 Feb 7]. Available from: https:\/\/www.jnj.com\/media-center\/press-releases\/janssen-announces-u-s-fda-approval-of-spravatotm-esketamine-ciii-nasal-spray-for-adults-with-treatment-resistant-depression-trd-who-have-cycled-through-multiple-treatments-without-relief"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1159\/000510703"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02565-4"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.13370"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811251365167"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53363-y"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12779-5"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1320802"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20022208"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.70319"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/19585969.2025.2480566"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253241243242"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.254"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2529-7029"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230890"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116337"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.92a.24032"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674231200164"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibae053"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/20008066.2024.2378651"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1025726"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116532"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437231225937"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2018.009"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811251353250"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2025.2520221"},{"issue":"8","key":"e_1_3_5_83_1","first-page":"702","article-title":"Van Adam tot ecstacy: Legaal gebruik van MDMA in de jaren 70 en 80 van de twintigste eeuw","volume":"62","author":"Blok G","year":"2020","unstructured":"Blok G. Van Adam tot ecstacy: Legaal gebruik van MDMA in de jaren 70 en 80 van de twintigste eeuw. Tijdschr Voor Psychiatr. 2020;62(8):702\u2013706.","journal-title":"Tijdschr Voor Psychiatr"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.110593"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.07.028"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf0435"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2654682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:02:07Z","timestamp":1777017727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2654682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3,24]]}},"alternative-id":["10.1080\/14656566.2026.2654682"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2654682","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}